When did BEONE MEDICINES LTD-ADR (ONC) report earnings last quarter?
BEONE MEDICINES LTD-ADR (ONC) last reported earnings on 2/26/2026.
BEONE MEDICINES LTD-ADR (ONC) Earnings History & Surprises
NASDAQ:ONC • US07725L1026
Current stock price
276.95 USD
-6.5 (-2.29%)
At close:
276.95 USD
0 (0%)
After Hours:
ONC Earnings overview
Past quarterly earnings results for BEONE MEDICINES LTD-ADR (ONC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- CN¥6.86
- Revenue Estimate
- 10.501B
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- CN¥3.92
- EPS Surprise
- -54.81%
- Revenue Surprise
- -3.11%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in CNY): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 3.92 | 8.68 | -54.81% | -98.75% | 10.618B | 10.959B | -3.11% | 34.26% |
| Q3 2025 | 7.94 | 8.40 | -5.45% | 188.84% | 10.108B | 10.247B | -1.36% | 40.84% |
| Q2 2025 | 5.41 | 0.42 | 1,187.13% | 104.68% | 9.47B | 8.91B | 6.29% | 40.76% |
| Q1 2025 | 124.55 | -4.14 | 3,109.85% | 151.87% | 8.074B | 8.176B | -1.25% | 50.65% |
| Q4 2024 | 314.05 | 16.52 | 1,800.57% | 1,260.99% | 7.908B | 7.496B | 5.50% | 73.88% |
| Q3 2024 | -8.94 | -7.28 | -22.81% | -159.34% | 7.176B | 7.158B | 0.26% | 27.60% |
| Q2 2024 | -115.45 | -12.74 | -805.99% | -323.98% | 6.728B | 5.255B | 28.03% | 60.77% |
| Q1 2024 | -240.13 | -21.85 | -999.20% | -856.85% | 5.359B | 4.557B | 17.61% | 74.78% |
| Q4 2023 | -27.05 | -11.48 | -135.57% | 18.03% | 4.548B | 4.07B | 11.75% | 68.60% |
| Q3 2023 | 15.07 | -26.33 | 157.25% | 138.68% | 5.624B | 4.108B | 36.90% | 111.55% |
| Q2 2023 | -27.23 | -25.21 | -8.03% | 30.85% | 4.185B | 3.256B | 28.53% | 84.97% |
| Q1 2023 | -25.10 | -24.79 | -1.25% | 15.81% | 3.066B | 2.897B | 5.85% | 57.42% |
| Q4 2022 | -33.00 | -13.16 | -150.68% | 25.20% | 2.698B | 2.44B | 10.56% | 98.00% |
| Q3 2022 | -38.96 | -39.07 | 0.28% | - | 2.659B | 2.406B | 10.50% | 99.05% |
| Q2 2022 | -39.38 | -30.81 | -27.81% | - | 2.262B | 2.048B | 10.47% | 135.16% |
| Q1 2022 | -29.81 | -26.47 | -12.63% | - | 1.948B | 1.838B | 5.98% | -50.42% |
| Q4 2021 | -44.12 | -35.29 | -25.02% | - | 1.362B | 1.413B | -3.58% | 105.94% |
| Q3 2021 | - | - | 1.336B | - | -8.44% | |||
| Q2 2021 | - | - | 962.051M | - | - | |||
| Q1 2021 | - | - | 3.929B | - | - | |||
| Q4 2020 | - | - | 661.572M | - | - | |||
| Q3 2020 | - | - | 1.459B | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
1,523.03%
Max EPS beat (4)
3,109.85%
Min EPS beat (4)
-5.45%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
2.29%
Max Revenue beat (4)
6.29%
Min Revenue beat (4)
-1.36%
Analysis
In the last 4 quarters, ONC has beaten EPS estimates in 3 out of 4 releases
ONC has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, ONC has beaten the EPS estimates by 1523.0% on average.
In the last 4 quarters, ONC has beaten the revenue estimates by 2.3% on average.
Related analysis
BEONE MEDICINES LTD-ADR / ONC Earnings FAQ
Did ONC stock beat earnings estimates in the most recent quarter?
BEONE MEDICINES LTD-ADR (ONC) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does BEONE MEDICINES LTD-ADR (ONC) beat earnings estimates?
In the last 4 quarters, BEONE MEDICINES LTD-ADR (ONC) has beaten EPS estimates in 3 out of 4 releases.